Fig. 18
From: The progression of inorganic nanoparticles and natural products for inflammatory bowel disease
Anti-inflammatory mechanism of resveratrol in IBD treatment. ARE antioxidant response element, Akt protein kinase B, HIF-1α hypoxia-inducing factor 1-α, ILs interleukin, JNK c-Jun N-terminal kinase, mTOR mammalian target of rapamycin, NF-kB nuclear factor-κB, Nrf2 transcription factor NF-E2 related factor 2, PI3K phosphoinositol 3-kinase, SIRT1 Sirtuin 1, STAT3 signal sensor and transcriptional activator 3, TGF-β transforming growth factor β, TREG regulatory T cell, VEGFA vascular endothelial growth factor A. (Quoted in Gowd et al. [155])